[ Price : $8.95]
Boston Scientific recalls (Class 1) its Carotid Wallstent Monorail Endoprosthesis due to a manufacturing defect that created an in...[ Price : $8.95]
A new Form FDA-483 cites significant GMP issues at the plant that makes Regenerons Eylea HD (aflibercept), delaying review of two ...[ Price : $8.95]
FDA clears a Signos 510(k) for what the company says is the first over-the-counter glucose monitoring system designed specifically...[ Price : $8.95]
FDA accepts for review a Stealth BioTherapeutics NDA resubmission for elamipretide for treating Barth syndrome, with the agency ag...[ Price : $8.95]
Nicox plans an NDA early next year after new data from its DENALI Phase 3 study of glaucoma therapy NCX 470 showed promising resul...[ Price : $8.95]
Researchers call for greater transparency of artificial intelligence/machine learning training and validation datasets in devices ...[ Price : $8.95]
FDA approves an Ionis Pharmaceuticals NDA for Dawnzera (donidalorsen) as the first RNA-targeted prophylactic treatment for heredit...[ Price : $8.95]
AbbVie reports that its JAK inhibitor Rinvoq (upadacitinib) met primary and secondary endpoints in a pivotal Phase 3 study testing...